Search for:

In brief

The High Court refused a consumer’s attempt to re-file a failed claim after the lower court issued a final and unappealable decision.

The consumer first brought a claim against e-commerce platform Lazada at the Small Claims Tribunal. After a decision was made, the consumer applied to the District Court for leave to appeal against the decision. The District Court refused to grant leave to appeal which, under law, is considered as final.

However, the consumer still brought a claim before the High Court, arguing that she was filing a fresh claim in respect of the damages that were not granted. The claim was refused.

Key takeaways

  • Parties cannot get around a final and unappealable decision by attempting to file the same claim disguised as a fresh claim.
  • In the context of consumer claims against sellers, the nature of damages claimed should not be too remote.

In more detail

The plaintiff, Lakshmi d/o Kumaravelu, purchased a dishwasher on Lazada’s online platform. She brought a claim before the Small Claims Tribunal against Lazada to seek a refund for the amount she paid for the dishwasher and sought damages of SGD 1,124.51 for suffering eczema, which she claimed was a result of her dealing with Lazada’s customer service. The price of the dishwasher was disputed.

The Small Claims Tribunal found that the plaintiff had not proven that Lazada caused her eczema and that the nature of such damage was too remote to be claimable. Hence, the Small Claims Tribunal only ordered Lazada to refund the sum paid for the dishwasher at the price Lazada argued the dishwasher was.

The plaintiff applied to the District Court for leave to appeal against the Small Claims Tribunal’s decision with regard to the SGD 26.02 price difference of the dishwasher’s price (that was disputed) and for her damages for eczema. Under the Small Claims Tribunal Act, an appeal may only be brought if the District Court grants leave and the District Court’s decision on whether to grant leave is final. In this case, the District Court refused to grant leave.

Despite the District Court’s final and unappealable decision, the plaintiff proceeded to file a claim in the General Division of the High Court, arguing that the claim could be regarded as a fresh claim in respect of the reliefs that were not granted. The High Court ruled that this was an attempt to get around the lower courts’ unappealable decision; the plaintiff had no right to such appeal; and the dismissal of the plaintiff’s application to the District Court for leave to appeal was final.

* * * * *


Baker McKenzie Wong & Leow is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a “partner” means a person who is a partner or equivalent in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.


Andy Leck is the managing principal of Baker McKenzie.Wong & Leow. Mr. Leck is recognised by the world’s leading industry and legal publications as a leader in his field. Asian Legal Business notes that he “always gives good, quick advice, [is] client-focused and has strong technical knowledge for his areas of practice”. Alongside his current role as managing principal, Mr. Leck has held several leadership positions in the Firm and externally as a leading IP practitioner. He currently serves on the International Trademark Association's Board of Directors and is a member of the Singapore Copyright Tribunal.


Ren Jun is an associate principal of Baker & McKenzie.Wong & Leow. Ren Jun extensively represents local and international intellectual property-intensive clients in both contentious and non-contentious IP matters, such as anti-counterfeiting; civil and criminal litigation; commercial issues; regulatory clearance; and advertising laws. Ren Jun also advises on a wide range of issues relating to the healthcare industries. These include regulatory compliance in respect of drugs, medical devices, clinical trials, health supplements and cosmetics; product liability and recall; and anti-corruption. Ren Jun is currently a member of the Firm's Asia Pacific Healthcare ASEAN Economic Community; Product Liability and Regulatory Sub-Committees.

Write A Comment